LT-00786

N/A

Report date: 2026/01/29 16:01:05
NME

Base Information

Drug NameLT-00786
Drug Alias Nameglycopeptides (LEAD Therapeutics)LT-29LT-00029LT-00786
ClassificationSmall molecules > Heterocyclic drugs > AntibioticsSmall molecules > Synthetic peptide
Mechanisms of ActionBacterial cell wall synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsGram-Negative Bacterial InfectionsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLead Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiomarin Pharmaceutical IncLead Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsGram-Negative Bacterial InfectionsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A